Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Processa Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Processa Pharmaceuticals Inc. July 30, 2026100.0%
-
Processa Pharmaceuticals Inc. July 18, 2025100.0%
-
Processa Pharmaceuticals Inc. June 28, 2024100.0%
-
Processa Pharmaceuticals Inc. June 27, 2023100.0%
-
Longeveron Inc. June 9, 202399.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2026 | Processa Pharmaceuticals Inc. | Option exercise | +203 | — | — |
| Mar 31, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +2,269 | $2.54 | $5,763 |
| Aug 11, 2025 | Longeveron Inc. | Open-market purchase | +11,766 | — | — |
| Jul 15, 2025 | Longeveron Inc. | Grant or award | +17,000 | — | — |
| Dec 2, 2024 | Longeveron Inc. | Open-market sale | −1,250 | $2.07 | $2,588 |
| Aug 15, 2024 | Longeveron Inc. | Grant or award | +23,500 | — | — |
| Jun 9, 2024 | Longeveron Inc. | Shares withheld for tax | −125 | $1.06 | $133 |
| Dec 29, 2023 | Longeveron Inc. | Open-market purchase | +8,322 | $1.43 | $11,900 |
| Dec 28, 2023 | Longeveron Inc. | Open-market purchase | +1,678 | $1.40 | $2,349 |
| Jun 27, 2023 | Processa Pharmaceuticals Inc. | Option exercise | +15,455 | — | — |
| Jun 9, 2023 | Longeveron Inc. | Grant or award | +5,000 | — | — |
| Feb 9, 2023 | Processa Pharmaceuticals Inc. | Grant or award | +12,500 | $0.80 | $10,000 |
Questions about Khoso Baluch
What boards is Khoso Baluch on?
Khoso Baluch sits on the boards of Longeveron Inc. and Processa Pharmaceuticals Inc.
How long has Khoso Baluch served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.